EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus

According to international consensus, metformin is acknowledged as a first-line therapeutic agent for type 2 diabetes mellitus (T2DM). However, in most cases this treatment eventually requires intensification by supplementation with other hypoglycemic medications. The aim of the EDGE study (Effectiv...

Full description

Saved in:
Bibliographic Details
Main Author: Gagik Radikovich Galstyan
Format: article
Language:EN
RU
Published: Endocrinology Research Centre 2013
Subjects:
Online Access:https://doaj.org/article/05a818a1512f45d2a2c1afbc3ea75738
Tags: Add Tag
No Tags, Be the first to tag this record!